Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed stock exchanges about a post-results conference call scheduled for Tuesday, 5th August 2025 at 4:30 PM IST. The call is meant only for analysts and institutional investors to discuss the company's Q1 FY26 unaudited financial results. Senior management including both Managing Directors (Pranav Amin and Shaunak Amin), Executive Director R.K. Baheti, CFO G Krishnan, Head of International Business Nilesh Wadhwa, and Sr. VP Finance Ajay Kumar Desai will represent the company. Dial-in numbers have been provided for participants in India, USA, UK, Singapore, and Hong Kong, along with a Diamond Pass registration link.
This is a routine regulatory disclosure informing the market about the upcoming earnings call. Retail investors may gain indirect insights once management's commentary is shared by analysts, but the call itself is restricted to institutional participants. The announcement itself is unlikely to move the stock price significantly.